In contrast, a history of hypertension (B = 0.222, 95%CI [0.068–0.375], t = 2.913, p = 0.0060) and the presence of macular edema at baseline (B = 0.297, 95%CI [0.040–0.555], t = 2.330, p = 0.025) were risk factors for BCVA after anti-VEGF injections. This evidence concerns the gene VEGFA and macular retinal edema.